POLISCOPE
Topic19 documents tagged

Drug Regulation

What This Page Covers

This page collects the 19 public records POLISCOPE has tagged with “Drug Regulation”. Coverage spans bills and news coverage - each decoded into plain English and linked to its primary source. It most often overlaps with Fda, Healthcare, and Law Enforcement.

Active Bills

Federal BillFEDERALSep 16, 2026Congress classifies xylazine as a Schedule III controlled substance and imposes federal tracking and criminal penaltiesFederal legislation classifies xylazine as a Schedule III controlled substance under the Controlled Substances Act, subjecting its illicit use, manufacturing, and distribution to criminal penalties anFederal BillFEDERALJul 20, 2026Proposed Faster Approval Process for Over-the-Counter DrugsFederal BillFEDERALApr 16, 2026Securing America’s Drug Supply from Communist China Act

Recent Activity

  1. Fri, Aug 281 item
    1. DEA revokes nurse practitioner's prescribing authority following allegations of illegal opioid distributionThe U.S. Drug Enforcement Administration (DEA) has revoked the prescribing authority of nurse practitioner Joan Rubinger after alleging she issued hundreds of thousands of illegal opioid prescriptionsMiami-Dade County
  2. Thu, Jul 302 items
    1. Florida's ban on potent kratom derivative faces chemical workaroundsIn June 2025, Florida classified the concentrated kratom derivative 7-hydroxymitragynine (7-OH) as a Schedule I narcotic. Despite this, manufacturers have modified their chemical formulas to continue Hillsborough County2 reports
    2. Florida's ban on potent kratom derivative faces challenges from synthetic manufacturersHillsborough County
  3. Tue, May 51 item
    1. Abortion Pills Remain Accessible After Supreme Court Intervention in Legal ChallengeFollowing the overturning of Roe v. Wade, access to abortion pills, particularly mifepristone, has become a central battleground. A recent legal challenge by Louisiana sought to restrict nationwide acUnited States
  4. Mon, May 41 item
    1. Supreme Court Temporarily Restores Access to Abortion Pill Amid Legal BattleThe U.S. Supreme Court has temporarily reinstated access to the abortion pill mifepristone, halting a federal appeals court decision that had sought to block its nationwide availability via mail. ThisUnited States

Finance Signals

No finance signals found for this topic in the available records yet.

Trace money trail →

Open the Money page to search by entity, donor, or PAC.

Reported financial relationships and timing signals. This does not prove motive or influence.

Key Actors

  1. 01Food and Drug Administrationorganization5 mentions
  2. 02Michael Walkerperson3 mentions
  3. 03Dr. Kurt Devineperson3 mentions
  4. 04James Uthmeierperson3 mentions
  5. 05Dr. Marty Makaryperson3 mentions
  6. 06MGM-15other3 mentions
  7. 07Floridaplace3 mentions
  8. 087-hydroxymitragynineother3 mentions
  9. 09Javohn Brownperson3 mentions
  10. 10mifepristoneother2 mentions

Connections Preview

Lightweight relationship summary. Open the full graph for the interactive view, including 1-hop neighbours and money edges.

  • Topic to billsCongress classifies xylazine as a Schedule III controlled substance and imposes federal tracking and criminal penalties, Proposed Faster Approval Process for Over-the-Counter Drugs, Securing America’s Drug Supply from Communist China Act
  • Topic to peopleMichael Walker, Dr. Kurt Devine, James Uthmeier (+2 more)
  • Topic to orgsFood and Drug Administration
Open the relationship graph →

Source Trail

Documents whose extracted record lists this topic. Each item opens the Bill Dossier, which includes the official source URL when available.

  1. Sep 16, 2026Federal BillCongress classifies xylazine as a Schedule III controlled substance and imposes federal tracking and criminal penalties
  2. Aug 28, 2026NewsDEA revokes nurse practitioner's prescribing authority following allegations of illegal opioid distribution
  3. Jul 30, 2026NewsFlorida's ban on potent kratom derivative faces challenges from synthetic manufacturers
  4. Jul 30, 2026NewsFlorida's ban on potent kratom derivative faces chemical workarounds
  5. Jul 30, 2026NewsFlorida's ban on potent kratom derivative faces chemical workarounds
  6. Jul 20, 2026Federal BillProposed Faster Approval Process for Over-the-Counter Drugs
  7. May 5, 2026NewsAbortion Pills Remain Accessible After Supreme Court Intervention in Legal Challenge
  8. May 4, 2026NewsSupreme Court Temporarily Restores Access to Abortion Pill Amid Legal Battle
  9. Apr 16, 2026Federal BillSecuring America’s Drug Supply from Communist China Act
  10. Jan 1, 2018hearing transcriptCongressional Hearing on FDA Drug Approval Fees

Showing 10 of 19 source records.